Biomedical considerations must not be compromised in favor of creating overcomplexified systems which, while potentially attractive from an academic perspective, are unlikely to make it beyond the research stage. Striking a balance between innovation and feasibility of translation to real word application is crucial. Keeping fabrication costs affordable would help ensure broader accessibility for patients worldwide, regardless of their financial means or healthcare coverage.